Skip to main content
NTRA
NASDAQ Life Sciences

Natera Promotes 15-Year Veteran Moshkevich to CEO as Chapman Steps Down

Tom Rudovsky · Reported by BusinessWire
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$366.75
Mkt Cap
$52.434B
52W Low
$181
52W High
$437.408
52W Position info
103% above low
Off High info
16% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

NTRA has more than doubled off its 52-week low of $181 on elevated volume (1.9× avg).

Summary

Natera named Solomon Moshkevich CEO and board member effective immediately, replacing Steve Chapman, who becomes a consultant and board advisor. This is an internal promotion, not a disruption: Moshkevich joined in 2011, ran the oncology business as its first general manager, and oversaw the commercial build-out of Panorama, Prospera and Signatera. Chapman's exit comes on the same day the company reported Q3 revenue of $794.0 million, up 34.1%, and raised full-year guidance — so the transition lands on a strong operating run-rate rather than amid weakness. The quarter's EPS was USD -0.42. The board, including executive chairman and co-founder Matthew Rabinowitz, is publicly backing the successor, which limits the read-through to strategy continuity in oncology and MRD. Watch the 4:30 p.m. ET earnings call for any commentary on the handoff and whether the raised guidance stands unchanged.

At the time of this announcement, NTRA was trading at $366.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $52.4B. The 52-week trading range was $181.00 to $437.41. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

NTRA - Latest Insights

NTRA
Nov 06, 2026, 11:25 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $316.02
Real-time Price: $272.82 info
Change: -$43.20 (-14%) info
Market Cap: $39.609B info
NTRA
Nov 05, 2026, 4:49 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $293.97
Real-time Price: $272.82 info
Change: -$21.16 (-7%) info
Market Cap: $39.609B info
NTRA
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $363.76
Real-time Price: $272.82 info
Change: -$90.95 (-25%) info
Market Cap: $39.609B info
NTRA
Nov 03, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $380.77
Real-time Price: $272.82 info
Change: -$107.95 (-28%) info
Market Cap: $39.609B info
NTRA
Oct 09, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $391.54
Real-time Price: $272.82 info
Change: -$118.73 (-30%) info
Market Cap: $39.609B info